CD44 and breast carcinoma: The membrane-associated RING-CH (MARCH), transmembrane E3 ligase, is downregulated in breast cancer tissues and interacts with CD44, a glycoprotein target subject to MARCH8-dependent lysosomal degradation in breast cancer (Chen et al. 2018).